257 related articles for article (PubMed ID: 24936531)
1. Pharmacological profile of sulodexide.
Hoppensteadt DA; Fareed J
Int Angiol; 2014 Jun; 33(3):229-35. PubMed ID: 24936531
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological actions of sulodexide.
Ofosu FA
Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
[TBL] [Abstract][Full Text] [Related]
3. Sulodexide in the treatment of chronic venous disease.
Andreozzi GM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):73-81. PubMed ID: 22329592
[TBL] [Abstract][Full Text] [Related]
4. Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide.
Harenberg J
Med Res Rev; 1998 Jan; 18(1):1-20. PubMed ID: 9436179
[TBL] [Abstract][Full Text] [Related]
5. Sulodexide: a renewed interest in this glycosaminoglycan.
Lauver DA; Lucchesi BR
Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
[TBL] [Abstract][Full Text] [Related]
6. Development and use of sulodexide in vascular diseases: implications for treatment.
Coccheri S; Mannello F
Drug Des Devel Ther; 2013 Dec; 8():49-65. PubMed ID: 24391440
[TBL] [Abstract][Full Text] [Related]
7. Sulodexide: A new antithrombotic agent.
González-Larrocha O; Salazar-Tafur MF; Romero-Rojano P; Arízaga-Maguregui A
Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):116. PubMed ID: 27884448
[No Abstract] [Full Text] [Related]
8. Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease.
Mannello F; Ligi D; Raffetto JD
Int Angiol; 2014 Jun; 33(3):236-42. PubMed ID: 24936532
[TBL] [Abstract][Full Text] [Related]
9. Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study.
Coccheri S; Scondotto G; Agnelli G; Palazzini E; Zamboni V;
Eur Heart J; 2002 Jul; 23(13):1057-65. PubMed ID: 12093059
[TBL] [Abstract][Full Text] [Related]
10. Sulodexide in venous disease.
Carroll BJ; Piazza G; Goldhaber SZ
J Thromb Haemost; 2019 Jan; 17(1):31-38. PubMed ID: 30394690
[TBL] [Abstract][Full Text] [Related]
11. Biological and clinical effects of sulodexide in arterial disorders and diseases.
Coccheri S
Int Angiol; 2014 Jun; 33(3):263-74. PubMed ID: 24769553
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous leg ulcers with sulodexide.
Scondotto G; Aloisi D; Ferrari P; Martini L
Angiology; 1999 Nov; 50(11):883-9. PubMed ID: 10580352
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats.
Andriuoli G; Mastacchi R; Barbanti M
Thromb Res; 1984 Apr; 34(1):81-6. PubMed ID: 6729771
[TBL] [Abstract][Full Text] [Related]
15. Use of sulodexide in patients with peripheral vascular disease.
Lasierra-Cirujeda J; Coronel P; Aza M; Gimeno M
J Blood Med; 2010; 1():105-15. PubMed ID: 22282689
[TBL] [Abstract][Full Text] [Related]
16. [Sulodexide in conservative treatment of peripheral arterial diseases].
Kuznetsov MR; Kosykh IV; Yu TV; Kuznetsova VF; Magnitsky IA
Angiol Sosud Khir; 2015; 21(4):45-51. PubMed ID: 26824094
[TBL] [Abstract][Full Text] [Related]
17. Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide.
Adiguzel C; Iqbal O; Hoppensteadt D; Jeske W; Cunanan J; Litinas E; He Zhu ; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009 Oct; 15(5):501-11. PubMed ID: 19703818
[TBL] [Abstract][Full Text] [Related]
18. Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Andreozzi GM; Bignamini AA; Davì G; Palareti G; Matuška J; Holý M; Pawlaczyk-Gabriel K; Džupina A; Sokurenko GY; Didenko YP; Andrei LD; Lessiani G; Visonà A;
Circulation; 2015 Nov; 132(20):1891-7. PubMed ID: 26408273
[TBL] [Abstract][Full Text] [Related]
19. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
20. Sulodexide modifies intravascular homeostasis what affects function of the endothelium.
Połubińska A; Staniszewski R; Baum E; Sumińska-Jasińska K; Bręborowicz A
Adv Med Sci; 2013; 58(2):304-10. PubMed ID: 24421218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
